“Dark Matter” in Cancer Genome Prompts Immune Response
December 7, 2015 – Researchers at the Icahn School of Medicine at Mount Sinai have discovered a group of non-coding RNA molecules in cancer cells that sets off an immune response because they appear to have features similar to those of pathogens. As …
Mount Sinai Innovation Partners Launches New Web Resources for Faculty
Mount Sinai Innovation Partners, MSIP, is a business unit of the health system that facilitates the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships. MSIP recently launched new resources on their website, www.ip.mountsinai.org, for faculty, staff and …
Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research
November 10, 2015 – Boehringer Ingelheim today announced new collaborations with four major scientific partners to enrich research and development of novel therapeutic approaches for patients with inflammatory bowel disease (IBD), including the Icahn School of Medicine at Mount Sinai, Massachusetts General Hospital, …
‘JEDI’ Technology Awakens New Understanding of How Immune System Works
November 4, 2015 – When it comes to fending off disease and helping prevent people from falling ill, the body’s immune system — armed with T-cells that help eliminate cancer cells, virus-infected cells and more — is second to none. But exactly how …
Mount Sinai Innovation Awards
On Monday, October 26, 2015, Mount Sinai Innovation Partners sponsored the first ever Mount Sinai Innovation Awards Ceremony, celebrating five new honors that recognize significant contributions in biomedical education and industry. Through the dedication of presenters, participants, attendees, and our generous sponsors, SINAInnovations …
Celmatix Launches Personalized Reproductive Medicine (PReM) Initiative to Decode Fertility Potential
October 19, 2015 – Celmatix, a personalized medicine company focused on fertility and women’s health, today announced the launch of the Personalized Reproductive Medicine (PReM) Initiative, an alliance created to investigate what an individual’s genetic signature and personalized metrics say about his or …
Regeneron and Icahn School of Medicine at Mount Sinai Announce New Antibody Research Agreement
September 24, 2015 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and The Experimental Therapeutics Institute (ETI) at the Icahn School of Medicine at Mount Sinai today announced that they have entered into an agreement with the goal of accelerating the discovery of fully …
NeoStem, Inc. and AllCells, LLC to collaborate with Mount Sinai as part of $8.8 million Grant to Further Stem Cell Research
April 16, 2015 – Icahn School of Medicine at Mount Sinai (ISSMM) will be able to further develop new blood treatments for chemotherapy-resistant blood cancer and other genetic blood disorders thanks to an $8.8 million grant from the New York State Stem …
Philips and Mount Sinai Health System collaborate to advance clinical research through new digital pathology database and analytics
March 24, 2015 – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a joint development agreement with the Mount Sinai Health System, an integrated health system in New York, to create a state-of-the-art digital image repository of patient tissue samples and innovative data analytics to pursue the …
Icahn School of Medicine at Mount Sinai and LifeMap Solutions Launch Asthma Study for iPhone
March 9, 2015 – The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a subsidiary of BioTime (BTX), today announced the launch of a large-scale medical research study that uses the new ResearchKit framework developed by Apple to make it …